glp-1 news 2025 october 21 oct 16 A network meta-analysis backed weight-loss benefits with several obesity drug news today october

This increases its popularity among persons who are looking to have skin whitening, detoxifying effects, anti-aging effects, and achieving overall good health

Tirzepatide (brand names Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist that produces higher average weight loss, roughly 18 to 25% of body weight in clinical trials

Exposure to environmental toxins such as heavy metals (e.g., cadmium, lead) and endocrine-disrupting chemicals (e.g., bisphenol A, phthalates) can increase ROS production in spermatozoa

[DOI] [PubMed] [Google Scholar] 113.Fu X.T., Song K., Zhou J., Shi Y.H., Liu W.R., Tian M.X., Jin L., Shi G.M., Gao Q., Ding Z.B., et al